These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7228199)

  • 1. Immunological studies on monovalent Enhydrina schistosa antivenin.
    Gawade SP; Gaitonde BB
    Indian J Med Res; 1980 Dec; 72():895-900. PubMed ID: 7228199
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation of monovalent common Indian sea snake (Enhydrina schistosa) antivenin.
    Gawade SP; Buduk DP; Gaitonde BB
    Indian J Med Res; 1980 Nov; 72():747-52. PubMed ID: 7203579
    [No Abstract]   [Full Text] [Related]  

  • 3. The production and characteristics of a coral snake (Micrurus mipartitus Hertwigi) antivenin.
    Bolaños R; Cerdas L; Taylor R
    Toxicon; 1975 Mar; 13(2):139-42. PubMed ID: 1129821
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-neutralization by tiger snake (Notechis scutatus) antivenene and sea snake (Enhydrina schistosa) antivenene against several sea snake venoms.
    Baxter EH; Gallichio HA
    Toxicon; 1974 May; 12(3):273-8. PubMed ID: 4218381
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the method of determining the effect of antimyonecrotic factor antibody in Habu-antivenin [proceedings].
    Chinzei H
    Jpn J Med Sci Biol; 1978 Apr; 31(2):204-5. PubMed ID: 682381
    [No Abstract]   [Full Text] [Related]  

  • 6. Snake and spider antivenin: risks and benefits of therapy.
    Weisman RS; Lizarralde SS; Thompson V
    J Fla Med Assoc; 1996 Mar; 83(3):192-5. PubMed ID: 8920051
    [No Abstract]   [Full Text] [Related]  

  • 7. The toxicity and immunological properties of some sea-snake venoms with particular reference to that of Enhydrina schistosa.
    CAREY JE; WRIGHT EA
    Trans R Soc Trop Med Hyg; 1960 Jan; 54():50-67. PubMed ID: 13807689
    [No Abstract]   [Full Text] [Related]  

  • 8. The in vitro neuromuscular activity of Indo-Pacific sea-snake venoms: efficacy of two commercially available antivenoms.
    Chetty N; Du A; Hodgson WC; Winkel K; Fry BG
    Toxicon; 2004 Aug; 44(2):193-200. PubMed ID: 15246769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological studies on an Egyptian bivalent Naja antivenin.
    Mohamed AH; Darwish MA; Hani-Ayobe M
    Toxicon; 1974 May; 12(3):321-3. PubMed ID: 4458113
    [No Abstract]   [Full Text] [Related]  

  • 10. Venoms of coral snakes (Micrurus spp.): report on a multivalent antivenin for the Americas.
    Bolaños R; Cerdas L; Abalos JW
    Bull Pan Am Health Organ; 1978; 12(1):23-7. PubMed ID: 667406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-neutralisation of Australian brown and tiger snake venoms with commercial antivenoms: Cross-reactivity or antivenom mixtures?
    O'Leary MA; Schneider JJ; Krishnan BP; Lavis C; McKendry A; Ong LK; Isbister GK
    Toxicon; 2007 Aug; 50(2):206-13. PubMed ID: 17467763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatographic separation of the venom of Enhydrina schistosa (common sea snake) and characterisation of its principal toxic component.
    Gawade SP; Bhide MB
    Indian J Med Res; 1978 May; 67(5):854-61. PubMed ID: 680930
    [No Abstract]   [Full Text] [Related]  

  • 13. Comment on "Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms".
    da Silva WD; Tambourgi DV
    Toxicon; 2011 Jun; 57(7-8):1109-10. PubMed ID: 21524658
    [No Abstract]   [Full Text] [Related]  

  • 14. A new antivenom to treat eastern coral snake (Micrurus fulvius fulvius) envenoming.
    Rawat S; Laing G; Smith DC; Theakston D; Landon J
    Toxicon; 1994 Feb; 32(2):185-90. PubMed ID: 8153957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemical and biochemical comparisons of equine monovalent and polyvalent snake antivenoms.
    Raweerith R; Ratanabanangkoon K
    Toxicon; 2005 Mar; 45(3):369-75. PubMed ID: 15683876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological studies on polyvalent and monovalent snake antivenins.
    Mohamed AH; Khalil FK; Baset AA
    Toxicon; 1977; 15(4):271-5. PubMed ID: 407671
    [No Abstract]   [Full Text] [Related]  

  • 17. The stability of refined antivenin.
    Christensen PA
    Toxicon; 1975 Feb; 13(1):75-7. PubMed ID: 1052565
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation and characterisation of toxic components from the venom of the common Indian sea snake (Enhydrina schistosa).
    Gawade SP; Gaitonde BB
    Toxicon; 1982; 20(4):797-801. PubMed ID: 6291197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. North American coral snake antivenin for the neutralization of non-native elapid venoms in a murine model.
    Richardson WH; Tanen DA; Tong TC; Betten DP; Carstairs SD; Williams SR; Cantrell FL; Clark RF
    Acad Emerg Med; 2006 Feb; 13(2):121-6. PubMed ID: 16436788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of assays for testing the neutralizing ability of antivenoms.
    Gutiérrez JM; Rojas G; Lomonte B; Gené JA; Chaves F; Alvarado J; Rojas E
    Toxicon; 1990; 28(10):1127-9; author reply 1129-32. PubMed ID: 2264065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.